Delivery Order SPE2DB20D9331-SPE2DB24FL1V6

Award Date 9/29/24
Potential Completion Date 10/21/24
Potential Value $48K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,850.28 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of 4,567,978,103 units of Botox 100 unit vials, with a performance period through May 6, 2025. This delivery order is part of a larger indefinite delivery contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC enables the DLA to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $48,455.40, is for the delivery of 4,565,763,594 units of Botox 100-unit vials. The award has no set-aside designation and is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA valued at up to $499,999,999, which allows the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $48,569.85 contract is for the delivery of 4,568,360,804 vials of Botox 100 unit medication. The contract has an ultimate completion date of June 11, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA under...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $6,922.20, is for the delivery of 4,565,482,216 vials of Botox 100 unit. The contract has an ultimate completion date of September 5, 2024. This delivery order is placed under a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $27,543.00, is for the delivery of 4,568,166,093 units of Botox 200 unit vials. The contract has an ultimate completion date of May 27, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the...
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4,563,249,905 units of BOTOX 100-unit vials. The order has a potential value of $4,614.80 and a completion date of January 24, 2024. This delivery order is part of DMS Pharmaceutical Group's existing prime vendor contract to supply pharmaceuticals and medical supplies to military treatment facilities globally. The company has...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $5,508.60, is for the delivery of 4,567,998,778 units of Botox 200 unit vials. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) awarded to DMS Pharmaceutical Group by the DLA under the SPE2DB program. This IDC enables the DLA to issue firm fixed-price delivery orders for a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $16,613.28, is for the supply of 100-unit vials of Botox to support the recurring medical supply needs of military health facilities. The delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, that allows the...
This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,614.80, is for the delivery of 4,565,109,356 vials of Botox 100 unit. The contract is not set aside and is part of a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA, valued at up to $499,999,999, which runs...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Botox 100 unit vials and has a ceiling value of $1,850.28. The delivery order was issued under DMS Pharmaceutical Group's existing $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which covers a comprehensive range of pharmaceutical...
  • SPE2DB20D9331
    Indefinite Delivery Contract
  • SPE2DB20D9331-SPE2DB24FL1V6
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $48,455.40, is for the delivery of 4,565,988,703 vials of Botox 100 unit injections. The period of performance runs through October 21, 2024.

This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which provides for the supply of a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities worldwide. As a prime vendor for the DLA's Medical Supply Chain, DMS Pharmaceutical Group plays a critical role in the federal pharmaceutical supply chain, delivering both routine and specialized medications to Department of Defense (DoD) and Department of Veterans Affairs (VA) medical centers.

Generated 1/9/25, 9:08 AM